Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors
a Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China
b Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China
c Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
d Institute of Pharmaceutical Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China
e Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium
收起